What Is the Prostate Cancer Drug Alpharadin?
The Food and Drug Administration (FDA) has announced it will fast-track the new prostate cancer drug Alpharadin. Fast-tracking a drug speeds up its approval process by around six months. Alpharadin got the green light because recent clinical trial results showed the drug improved overall survival in men with hormone therapy resistant prostate cancer and symptoms…